André Costa Meireles
Research Subjects
Research Interests
André Costa Meireles has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Bruna de Sá Barreto Pontes
Bahiana School of Medicine and Public Health, Salvador, Brazil
2 shared publications - Gabriela Bagano
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRPUSP), Ribeirão Preto – SP, Brasil
2 shared publications - João Vitor Miranda Porto Oliveira
Bahiana School of Medicine and Public Health, Salvador, Brazil
2 shared publications - Luis Cláudio Lemos Correia
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
2 shared publications - Milton Henrique Vitoria de Melo
Bahiana School of Medicine and Public Health, Salvador, Brazil
2 shared publications - Thomaz Emanoel Azevedo Silva
Bahiana School of Medicine and Public Health, Salvador, Brazil
2 shared publications
Latest Publications
- Open Access
- 13 July 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (14) , 1514
Comprehensive Study of the IBMP ELISA IgA/IgM/IgG COVID-19 Kit for SARS-CoV-2 Antibody Detection
COVID-19 laboratory diagnosis primarily relies on molecular tests, highly sensitive during early infection stages with high viral loads. As the disease progresses, sensitivity decreases, requiring antibody detection. Since the beginning of the pandemic, serological tests have been developed and made available in Brazil, but their diagnostic performance varies. This study evaluated the IBMP ELISA IgA/IgM/IgG COVID-19 kit performance in detecting SARS-CoV-2 antibodies. A total of 90 samples, including 64 from COVID-19 patients and 26 pre-pandemic donors, were assessed based on time post symptom onset (0–7, 8–14, and 15–21 days). The kit showed 61% sensitivity, 100% specificity, and 72% accuracy overall. Sensitivity varied with time, being 25%, 57%, and 96% for 0–7, 8–14, and 15–21 days, respectively. Similar variations were noted in other commercial tests. The Gold ELISA COVID-19 (IgG/IgM) had sensitivities of 31%, 71%, and 100%, while the Anti-SARS-CoV-2 NCP ELISA (IgG) and Anti-SARS-CoV-2 NCP ELISA (IgM) showed varying sensitivities. The IBMP ELISA kit displayed high diagnostic capability, especially as the disease progressed, complementing COVID-19 diagnosis. Reproducibility assessment revealed minimal systematic and analytical errors. In conclusion, the IBMP ELISA IgA/IgM/IgG COVID-19 kit is a robust tool for detecting anti-SARS-CoV-2 antibodies, increasing in efficacy over the disease course, and minimizing false negatives in RT-PCR COVID-19 diagnosis.
- 13 July 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (14) , 1514
Open AccessComprehensive Study of the IBMP ELISA IgA/IgM/IgG COVID-19 Kit for SARS-CoV-2 Antibody Detection
COVID-19 laboratory diagnosis primarily relies on molecular tests, highly sensitive during early infection stages with high viral loads. As the disease progresses, sensitivity decreases, requiring antibody detection. Since the beginning of the pandemic, serological tests have been developed and made available in Brazil, but their diagnostic performance varies. This study evaluated the IBMP ELISA IgA/IgM/IgG COVID-19 kit performance in detecting SARS-CoV-2 antibodies. A total of 90 samples, including 64 from COVID-19 patients and 26 pre-pandemic donors, were assessed based on time post symptom onset (0–7, 8–14, and 15–21 days). The kit showed 61% sensitivity, 100% specificity, and 72% accuracy overall. Sensitivity varied with time, being 25%, 57%, and 96% for 0–7, 8–14, and 15–21 days, respectively. Similar variations were noted in other commercial tests. The Gold ELISA COVID-19 (IgG/IgM) had sensitivities of 31%, 71%, and 100%, while the Anti-SARS-CoV-2 NCP ELISA (IgG) and Anti-SARS-CoV-2 NCP ELISA (IgM) showed varying sensitivities. The IBMP ELISA kit displayed high diagnostic capability, especially as the disease progressed, complementing COVID-19 diagnosis. Reproducibility assessment revealed minimal systematic and analytical errors. In conclusion, the IBMP ELISA IgA/IgM/IgG COVID-19 kit is a robust tool for detecting anti-SARS-CoV-2 antibodies, increasing in efficacy over the disease course, and minimizing false negatives in RT-PCR COVID-19 diagnosis.
- Open Access
Lack of Accuracy of the GRACE score to Predict Coronary Anatomy in Acute Coronary Syndromes
Introduction Coronary anatomy is one of the strongest risk predictors in Acute Coronary Syndromes (ACS), which justifies early coronary angiography. Diagnostic scores for predicting outcomes are usually superior to clinical judgment. Despite being validated for prognosis, the GRACE score has been used to discriminate patients with high or low probability of anatomical severity. Objective To test the hypothesis that the GRACE score actually predicts anatomical severity. Methods The study was carried out by assessing consecutive patients with ACS who underwent invasive angiography. Severe anatomical disease was defined as obstructive involvement (≥ 70% in diameter) in (1) left main coronary artery or (2) double or triple vessel disease involving proximal left anterior descending artery or (3) subocclusion. The GRACE score was evaluated under numerical and dichotomous tests. Results A total of 733 patients were evaluated, aged 63 ± 14 years, 61% male and GRACE score of 119 ± 37. Obstructive coronary disease was observed in 81% of the patients, classified as one, two or three vessel disease, or left main coronary artery involvement in 28%, 23%, 26% and 4%, respectively. The area under the ROC curve of the GRACE score was 0.65 (95% CI = 0.61 - 0.69) for predicting severe disease. The cutoff point below which the first GRACE tertile is defined (109) was used to dichotomize low-risk (N = 318) and medium-high-risk (N = 415) samples. This standard definition of intermediate-high risk by the GRACE score (> 109) revealed sensitivity of 67% in detecting severe anatomy (95% CI = 61% - 72%) and specificity of 50% (95% CI = 46% - 55%), resulting in positive likelihood ratio of 1.3 (95% CI = 1.2 - 1.5) and negative likelihood ratio of 0.66 (95% CI = 0.55 - 0.80). There was a weak correlation between GRACE and anatomical scores such as SYNTAX (r = 0.36, P < 0.001) and Gensini (r = 0.36, P < 0.001). Conclusion Despite statistical association with extent of anatomical coronary disease, the GRACE Score is not accurate to predict severity of disease before coronary angiography.
Open AccessLack of Accuracy of the GRACE score to Predict Coronary Anatomy in Acute Coronary Syndromes
Introduction Coronary anatomy is one of the strongest risk predictors in Acute Coronary Syndromes (ACS), which justifies early coronary angiography. Diagnostic scores for predicting outcomes are usually superior to clinical judgment. Despite being validated for prognosis, the GRACE score has been used to discriminate patients with high or low probability of anatomical severity. Objective To test the hypothesis that the GRACE score actually predicts anatomical severity. Methods The study was carried out by assessing consecutive patients with ACS who underwent invasive angiography. Severe anatomical disease was defined as obstructive involvement (≥ 70% in diameter) in (1) left main coronary artery or (2) double or triple vessel disease involving proximal left anterior descending artery or (3) subocclusion. The GRACE score was evaluated under numerical and dichotomous tests. Results A total of 733 patients were evaluated, aged 63 ± 14 years, 61% male and GRACE score of 119 ± 37. Obstructive coronary disease was observed in 81% of the patients, classified as one, two or three vessel disease, or left main coronary artery involvement in 28%, 23%, 26% and 4%, respectively. The area under the ROC curve of the GRACE score was 0.65 (95% CI = 0.61 - 0.69) for predicting severe disease. The cutoff point below which the first GRACE tertile is defined (109) was used to dichotomize low-risk (N = 318) and medium-high-risk (N = 415) samples. This standard definition of intermediate-high risk by the GRACE score (> 109) revealed sensitivity of 67% in detecting severe anatomy (95% CI = 61% - 72%) and specificity of 50% (95% CI = 46% - 55%), resulting in positive likelihood ratio of 1.3 (95% CI = 1.2 - 1.5) and negative likelihood ratio of 0.66 (95% CI = 0.55 - 0.80). There was a weak correlation between GRACE and anatomical scores such as SYNTAX (r = 0.36, P < 0.001) and Gensini (r = 0.36, P < 0.001). Conclusion Despite statistical association with extent of anatomical coronary disease, the GRACE Score is not accurate to predict severity of disease before coronary angiography.
- Open Access
Development of Diagnostic Score for Acute Pericarditis in Patients Admitted for Chest Pain
Background: Despite the presence of clinical, laboratory and electrocardiographic characteristics suggestive of acute pericarditis, there is no multivariate diagnostic score developed for this condition. Objective: To develop a clinical score for diagnosis of pericarditis as the cause of acute chest pain, using data from admission. Methods: In a diagnostic case-control study, we compared consecutive 45 patients of the Chest Pain Registry diagnosed of pericarditis (confirmed by magnetic resonance imaging or the presence of pleural effusion in echocardiography) versus 90 patients with an alternative confirmed diagnosis, randomly selected from our registry. Six clinical characteristics, 16 chest pain characteristics and 4 additional tests were candidates as predictors. Logistic regression was used to derivate a model composed by independent predictors of pericarditis. Results: Among 17 variables associated with pericarditis, 5 remained independent predictors: age; pain aggravation with thorax movement; positive troponin; diffuse ST-segment elevation and C-reactive protein. Each independent predictor was attributed points proportional to its regression coefficient. The final score presented discriminatory capacity represented by C-statistic of 0.97 (95% CI = 0.93 – 1.0). The best cutoff point was defined as > 6 points, with sensitivity of 96% (95% CI = 85 – 100), specificity of 87% (95% CI = 78 – 93), positive likelihood ratio of 7.2 (95% CI = 4.2 – 12) and negative likelihood ratio of 0.05 (95% CI = 0.01 – 0.2). Conclusion: The proposed multivariate score seems to be accurate for the diagnosis of pericarditis and require further validation in an independent sample.
Open AccessDevelopment of Diagnostic Score for Acute Pericarditis in Patients Admitted for Chest Pain
Background: Despite the presence of clinical, laboratory and electrocardiographic characteristics suggestive of acute pericarditis, there is no multivariate diagnostic score developed for this condition. Objective: To develop a clinical score for diagnosis of pericarditis as the cause of acute chest pain, using data from admission. Methods: In a diagnostic case-control study, we compared consecutive 45 patients of the Chest Pain Registry diagnosed of pericarditis (confirmed by magnetic resonance imaging or the presence of pleural effusion in echocardiography) versus 90 patients with an alternative confirmed diagnosis, randomly selected from our registry. Six clinical characteristics, 16 chest pain characteristics and 4 additional tests were candidates as predictors. Logistic regression was used to derivate a model composed by independent predictors of pericarditis. Results: Among 17 variables associated with pericarditis, 5 remained independent predictors: age; pain aggravation with thorax movement; positive troponin; diffuse ST-segment elevation and C-reactive protein. Each independent predictor was attributed points proportional to its regression coefficient. The final score presented discriminatory capacity represented by C-statistic of 0.97 (95% CI = 0.93 – 1.0). The best cutoff point was defined as > 6 points, with sensitivity of 96% (95% CI = 85 – 100), specificity of 87% (95% CI = 78 – 93), positive likelihood ratio of 7.2 (95% CI = 4.2 – 12) and negative likelihood ratio of 0.05 (95% CI = 0.01 – 0.2). Conclusion: The proposed multivariate score seems to be accurate for the diagnosis of pericarditis and require further validation in an independent sample.